Lido Advisors, LLC Innoviva, Inc. Transaction History

Lido Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$11.8 - $13.78 $33,335 - $38,928	2,825 Added 10.42%	29,928 $396,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $314,665 - $412,507	27,103 New	27,103 $314,000
Q2 2022 Aug 15, 2022	SELL	$14.32 - $19.88 $271,492 - $376,904	-18,959 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$15.39 - $20.25 $291,779 - $383,919	18,959 New	18,959 $366,000

228

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lido Advisors, LLC with notifications on news.